Why 20% of Patients May Not See Weight Loss Success with New Obesity Medications

Obesity treatments, specifically the medications Ozempic and Wegovy, have become popular for weight loss. However, about 20% of users may not see significant results. This means 1 in 5 patients might struggle with the drugs. Danielle Griffin, a user from New Mexico, has been on Wegovy for a year and a half but has only lost 13 pounds despite watching her diet and exercising.

Clinical trials showed that many users lost 15% to 22% of their body weight. However, around 10% to 15% were “nonresponders,” losing less than 5%. Dr. Fatima Cody Stanford highlights that genetics and hormones affect how individuals respond to these drugs. Conditions like sleep apnea and some medications can hinder weight loss efforts.

Dr. Katherine Saunders notes that patients often face disappointment when they do not achieve expected results. Griffin hoped to lose 70 pounds but found the process emotionally challenging.

Understanding Obesity Treatments: An Interview with Dr. Fatima Cody Stanford

NewsDirectory3: Thank you for joining us, Dr. Stanford. As obesity treatments like Ozempic and Wegovy become increasingly popular, can you explain why about 20% of users may not see significant results?

Dr. Stanford: Thank you for having me. The effectiveness of obesity medications like Ozempic and Wegovy can vary significantly among individuals. Clinical trials have shown impressive results for many users, with weight loss ranging from 15% to 22%. However, approximately 10% to 15% of participants are classified as “nonresponders,” losing less than 5% of their body weight. Several factors contribute to this variability, including genetics, hormonal influences, and existing medical conditions. For example, individuals with sleep apnea may struggle more with weight loss.

NewsDirectory3: We heard from Danielle Griffin, a user from New Mexico, who has been on Wegovy for 18 months but only lost 13 pounds. What might explain her experience?

Dr. Stanford: Danielle’s experience is not uncommon. Many individuals assume that simply taking these medications will lead to significant weight loss. However, weight management is complex and often requires simultaneous lifestyle changes, such as diet and exercise. Genetics and metabolism play crucial roles; what works for one person may not work for another. It’s important to approach these treatments as part of a broader strategy that includes personalized care and monitoring.

NewsDirectory3: The emotional aspect seems significant as well. Can you speak to Dr. Katherine Saunders’ observations regarding patient disappointment?

Dr. Stanford: Absolutely. The emotional burden of not meeting weight loss expectations can be quite challenging for patients. Many, like Danielle, set ambitious goals—like losing 70 pounds—and find themselves feeling discouraged when those goals aren’t met. This disconnect between expectation and reality can lead to frustration and impact overall mental health. Encouraging realistic goals and celebrating any progress, however small, is vital.

NewsDirectory3: We’ve also heard about side effects such as nausea. How do these affect patient adherence to medication?

Dr. Stanford: Side effects can significantly influence whether patients continue their treatment. While some may experience weight loss within weeks, others may face adverse effects, making it difficult to stay on track. It’s imperative for healthcare providers to communicate potential side effects upfront and monitor their patients’ experiences closely. This ongoing support can help patients manage any discomfort and adjust their treatment plans as necessary.

NewsDirectory3: Danielle has now switched to Zepbound, targeting different hormone pathways. What can you tell us about exploring alternative medications?

Dr. Stanford: Switching to a different medication can be a smart move, especially if the initial treatment isn’t yielding the desired results. Zepbound is designed to target additional hormone pathways, which may provide a more tailored approach to weight management. It’s essential for patients to work closely with their healthcare providers to find the most suitable and effective treatment, as not every medication will work for everyone. This personalized approach may offer patients a better chance of achieving their weight loss goals.

NewsDirectory3: In closing, what would you recommend for patients navigating obesity treatments?

Dr. Stanford: I advise patients to take a comprehensive approach to weight management. This includes exploring various treatments, making lifestyle changes, and having open discussions with healthcare providers about their experiences and challenges. Weight loss should not be viewed in isolation; it’s about overall health and well-being. Encouragement, support, and a realistic approach can help individuals manage their expectations and achieve sustainable results.

The medications typically require lifestyle changes too. Dr. Jody Dushay mentions that some patients may see weight loss within weeks, while others may not respond at all or may experience side effects like nausea.

Griffin has switched to a new drug, Zepbound, which targets additional hormone pathways. After three months, she has lost 7 pounds. Experts suggest exploring different obesity treatments and changing lifestyle habits can be beneficial. Comprehensive treatment is essential for effective weight management.